Publication | Closed Access
Loss of BRCA1 expression may predict shorter time-to-progression in metastatic breast cancer patients treated with taxanes.
37
Citations
16
References
2006
Year
These results suggest that the absence of BRCA1 expression is an independent predictor of shorter TTP in advanced breast cancer patients treated with taxane-based chemotherapy.
| Year | Citations | |
|---|---|---|
Page 1
Page 1